Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

Richard Ian Clegg has worked on the following 90 EPO patent applications which have been published in the last five years:

EP11724832

IMPLANTABLE MEDICAL DEVICES HAVING MICROPOROUS SURFACE LAYERS AND METHOD FOR REDUCING FOREIGN BODY RESPONSE TO THE SAME

IPC classification:
A61L 27/02, A61L 27/16, A61L 27/52, A61L 27/56
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11751374

APTAMERS TO 4-1BB AND THEIR USE IN TREATING DISEASES AND DISORDERS

IPC classification:
A61K 48/00, C07H 21/02
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP11791932

CYANOQUINOLINE DERIVATIVES

IPC classification:
A61K 31/4709, A61K 31/497, A61K 31/506, A61K 31/5377, A61P 35/00, C07D 401/12, C07D 401/14, C07D 405/12
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
The patent has been granted
EP11840099

POLYCOMB-ASSOCIATED NON-CODING RNAS

IPC classification:
C12N 15/113
Applicant:
The General Hospital Corporation
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP11769451

5-POSITION MODIFIED PYRIMIDINES AND THEIR USE

IPC classification:
C07H 19/073, C07H 19/10, C07H 21/04
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11852141

POLYCOMB-ASSOCIATED NON-CODING RNAS

IPC classification:
C12N 15/113
Applicant:
The General Hospital Corporation
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11832854

COMBINATION TREATMENT OF CANCER

IPC classification:
A61K 31/52, A61P 35/00
Applicant:
Agency for Science, Technology and Research
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12754934

APTAMERS FOR CLOSTRIDIUM DIFFICILE DIAGNOSTICS

IPC classification:
C07H 21/00, G01N 33/53
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12790157

BLOCKADE OF TL1A-DR3 INTERACTIONS TO AMELIORATE T CELL MEDIATED DISEASE PATHOLOGY AND ANTIBODIES THEREOF

IPC classification:
A61K 39/395, A61P 11/06, A61P 19/02, C12N 15/62
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP12806953

RNA-YY1 INTERACTIONS

IPC classification:
A61K 31/7105, A61K 31/711, A61P 35/00, C07H 21/02, C07H 21/04, C40B 40/06, C40B 50/06, G01N 33/68
Applicant:
The General Hospital Corporation
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12823662

DEVICE AND METHOD TO ACCURATELY AND EASILY ASSEMBLE GLASS SLIDES

IPC classification:
C12M 1/34
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12825069

A PROTEIN INVOLVED IN DETECTION OF CANCER METASTASIS AND A TREATMENT THEREOF

IPC classification:
A61K 38/17, A61K 39/00, A61P 35/04, C07K 16/18, C12N 15/113, C12Q 1/68, G01N 33/533
Applicant:
National University of Singapore
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12836076

CARDIOVASCULAR RISK EVENT PREDICTION AND USES THEREOF

IPC classification:
G01N 33/48, G01N 33/52
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12840785

IRON-FIBER COMPOSITION, PREPARATION AND USES THEREOF

IPC classification:
B32B 9/00
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12843012

SELECTION OF PREFERRED SAMPLE HANDLING AND PROCESSING PROTOCOL FOR IDENTIFICATION OF DISEASE BIOMARKERS AND SAMPLE QUALITY ASSESSMENT

IPC classification:
C12M 1/34
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP12863462

APTAMERS AND DIAGNOSTIC METHODS FOR DETECTING THE EGF RECEPTOR

IPC classification:
A61K 31/7072, C12N 15/115, C12Q 1/68
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12167750

Herpes Simplex Virus for the treatment of liver cancer

IPC classification:
A61K 31/4412, A61K 31/704, A61K 35/76, A61P 35/00
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13761420

ADJUVANT AND VACCINE COMPOSITIONS

IPC classification:
A61K 39/39
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13775956

RNA APTAMERS FOR THERAPEUTIC AND DIAGNOSTIC DELIVERY TO PANCREATIC CANCER CELLS

IPC classification:
A61K 31/7088, C07H 21/02, C12N 15/115, C12Q 1/68
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13774934

TUBERCULOSIS BIOMARKERS AND USES THEREOF

IPC classification:
C12Q 1/68
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13720737

VASCULAR ENDOTHELIAL GROWTH FACTOR ANTAGONISTS AND METHODS FOR THEIR USE

IPC classification:
A61K 38/18, C07K 14/71
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13724345

HERPES SIMPLEX VIRUS FOR THE TREATMENT OF LIVER CANCER

IPC classification:
A61K 31/4412, A61K 31/704, A61K 35/76, A61P 35/00
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13801106

APTAMER-BASED MULTIPLEXED ASSAYS

IPC classification:
C07H 21/00, C12Q 1/68, G01N 33/543
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP14194459

Aptamer therapeutics useful in the treatment of complement-related disorders

IPC classification:
A61K 31/7088, C12N 15/115, C12Q 1/68
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11835619

POLYMORPH OF N-(6-(4-CHLOROPHENOXY)HEXYL)-N'-CYANO-N''-(4-PYRIDYL)GUANIDINE, AND PREPARATION THEREFOR AND USE THEREOF

IPC classification:
A61K 31/4409, A61P 35/00, C07D 213/74
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13830027

USE OF P47 FROM PLASMODIUM FALCIPARUM (PFS47) OR PLASMODIUM VIVAX (PVS47) AS A VACCINE OR DRUG SCREENING TARGETS FOR THE INHIBITION OF HUMAN MALARIA TRANSMISSION

IPC classification:
A61K 39/015, C07K 14/445, C12N 15/30, C12N 15/63, G01N 33/15
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13836396

MULTIFUNCTIONAL ORAL VACCINE BASED ON CHROMOSOME RECOMBINEERING

IPC classification:
A61K 35/74, A61P 31/04, C12N 1/21, C12N 15/31
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11849550

NOVEL SUBSTITUTED BICYCLIC AROMATIC COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS

IPC classification:
A61K 31/216, A61P 11/06, C07C 65/105, C07C 65/24, C07D 213/79, C07D 215/06, C07D 215/20, C07D 217/16, C07D 239/28, C07D 253/10, C07D 401/04, C07D 401/10, C07D 405/04, C07D 409/14
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Agent:
Tara Romaine Jennings, F. R. Kelly & Co.
Status:
EXAMINATION IN PROGRESS
EP11849278

NOVEL SUBSTITUTED BICYCLIC AROMATIC COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS

IPC classification:
A61K 31/4709, A61K 31/498, A61P 11/06, C07C 65/24, C07D 213/79, C07D 215/06, C07D 215/20, C07D 215/60, C07D 217/16, C07D 239/28, C07D 241/24, C07D 253/10, C07D 401/04, C07D 401/10, C07D 403/10
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP10857614

NOVEL DIHYDROPYRIMIDIN-2(1H)-ONE COMPOUNDS AS NEUROKININ-3 RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/505, A61P 9/00, A61P 11/00, A61P 17/00, A61P 21/00, A61P 23/00, A61P 25/00, A61P 27/00, A61P 29/00, A61P 31/00, A61P 37/00, A61P 39/00
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14198571

Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics

IPC classification:
C12N 15/11
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15152547

Chemically modified aptamers with improved off-rates

IPC classification:
C12Q 1/68
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13871817

BIDIRECTIONAL WRENCH

IPC classification:
B25B 13/46
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14743879

METHODS AND KITS FOR TREATING AND CLASSIFYING INDIVIDUALS AT RISK OF OR SUFFERING FROM A NEUROLOGICAL DYSFUNCTION OR DISORDER

IPC classification:
A61P 25/28, C12Q 1/48, C12Q 1/68
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP15166660

DUAL VECTOR FOR INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS

IPC classification:
A01K 67/027, A61K 35/28, A61K 48/00, C07K 14/00, C07K 14/16, C07K 14/47, C12N 9/90, C12N 15/113, C12N 15/85, C12N 15/867
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15158380

KITS COMPRISING APTAMERS

IPC classification:
C12N 15/115, G01N 33/53
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP13709799

ASSAY FOR DETERMINING THE CELL NUMBER IN CULTURED CELLS

IPC classification:
G01N 33/50
Applicant:
Keele University
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14761246

SELF ASSEMBLING BETA-BARREL PROTEINS POSITION NANOTUBES

IPC classification:
B82Y 30/00, C08H 1/00, C08J 9/228
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14765516

BRIDGED BICYCLIC NUCLEOSIDES

IPC classification:
C07H 21/04, C12N 15/11
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14768310

LOCKED NUCLEIC ACID INHIBITOR OF MIR-145 AND USES THEREOF

IPC classification:
A61K 31/712
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15184135

Peptides deriving from Alternaria Alternata major allergen Alt a 1

IPC classification:
A61K 39/35, C07K 14/37, C07K 14/415, C07K 14/435
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14782975

METHOD FOR DETECTING PROTEIN STABILITY AND USES THEREOF

IPC classification:
C07K 2/00, C12N 15/62, C12N 15/65, G01N 21/64
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14783395

POLYCAPROLACTONE MICROCARRIERS FOR STEM CELL CULTURE AND FABRICATION THEREOF

IPC classification:
A61L 27/40, C12N 5/02, C12N 5/0735, C12N 5/074, C12N 5/0775
Applicant:
Agency for Science, Technology and Research
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14761117

METAL ION-FUNCTIONAL FIBER COMPONENT COMPLEX COMPOSITIONS, PREPARATION AND USES THEREOF

IPC classification:
A61K 33/24, A61P 3/02, B32B 9/00, C07F 15/02, A23L 33/16
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14765389

MYCELIATED COFFEE PRODUCTS AND METHODS FOR MAKING

IPC classification:
A23F 5/02, A23L 33/00
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15188374

DEVICES AND METHODS OF CELL CAPTURE AND ANALYSIS

IPC classification:
C12Q 1/02, G01N 33/53, G01N 33/574
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Agent:
Cooley (UK) LLP
Status:
EXAMINATION IN PROGRESS
EP14794681

SALTS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR

IPC classification:
C07D 239/48
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP13884688

HEPARAN SULPHATES

IPC classification:
A61K 31/727, A61P 19/08, C08B 37/10, C12P 19/04
Applicant:
Agency for Science, Technology and Research
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13150168

Aptamer therapeutics useful in the treatment of complement-related disorders

IPC classification:
A61K 31/7088, C12N 15/115, C12Q 1/68
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14808338

COMPOSITION FOR MAINTAINING PLATELET FUNCTION

IPC classification:
A61K 31/4439, A61K 31/444, A61K 35/14, A61P 7/00
Applicant:
Kyoto University
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14805119

HEPARAN SULPHATE

IPC classification:
A61F 2/00, A61K 31/727, C08B 37/10, C12N 5/02
Applicant:
Agency for Science, Technology and Research
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14806840

(+)-5-(3,4-DIFLUOROPHENYL)-5-[(3-METHYL-2-OXOPYRIDIN-1(2H)-YL)METHYL]IMIDAZOLIDINE-2,4-DIONE AND DRUG CONTAINING SAME

IPC classification:
A61K 9/06, A61K 9/08, A61K 31/4439, A61K 47/10, A61P 17/00, A61P 17/06, A61P 17/10, A61P 37/08, C07B 57/00, C07D 401/06
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14810407

METHODS AND KITS FOR TREATING AND CLASSIFYING INDIVIDUALS AT RISK OF OR SUFFERING FROM TRAP1 CHANGE-OF-FUNCTION

IPC classification:
C12Q 1/68
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14817065

HIGH-STABILITY T-CELL RECEPTOR AND PREPARATION METHOD AND APPLICATION THEREOF

IPC classification:
A61K 38/17, A61K 47/48, A61P 31/12, A61P 35/00, A61P 37/06, C07K 14/725, C12N 15/10, C12N 15/12, C12N 15/63
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14822991

NICOTINE SALT WITH M ETA-SALICYLIC ACID

IPC classification:
A61K 9/00, A61M 15/06, F24J 1/00
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP15189979

STABILIZED APTAMERS TO PLATELET DERIVED GROWTH FACTOR AND THEIR USE AS ONCOLOGY THERAPEUTICS

IPC classification:
A61K 31/337, A61K 31/427, A61K 31/4745, A61K 31/522, A61K 31/704, A61K 31/7048, A61K 31/7072, A61K 38/17, C07K 14/715, C12N 15/11, C12N 15/115
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
APPLICATION PUBLISHED
EP15191232

COMPLEMENT BINDING APTAMERS AND ANTI-C5 AGENTS USEFUL IN THE TREATMENT OF OCULAR DISORDERS

IPC classification:
A61K 48/00, C12N 15/115
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11753699

USE OF MARKERS OF UNDIFFERENTIATED PLURIPOTENT STEM CELLS

IPC classification:
C07D 409/14, C12N 5/0735
Applicant:
Agency for Science, Technology and Research
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12173138

Complement binding aptamers and anti-C5 agents useful in the treatment of ocular disorders

IPC classification:
A61K 48/00, C12N 15/115
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14781343

QUANTUM MOLECULAR SEQUENCING (QM-SEQ): IDENTIFICATION OF UNIQUE NANOELECTRONIC TUNNELING SPECTROSCOPY FINGERPRINTS FOR DNA, RNA, AND SINGLE NUCLEOTIDE MODIFICATIONS

IPC classification:
C12Q 1/68
Applicant:
The Regents of the University of Colorado
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP14847780

MULTIAPTAMER TARGET DETECTION

IPC classification:
C12N 15/115
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14854788

NANOPARTICLE COMPOSITIONS AND METHODS AS CARRIERS OF NUTRACEUTICAL FACTORS ACROSS CELL MEMBRANES AND BIOLOGICAL BARRIERS

IPC classification:
A61K 38/00
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14853519

YAP PROTEIN INHIBITING POLYPEPTIDE AND APPLICATION THEREOF

IPC classification:
A61K 38/10, A61P 35/00, C07K 7/08, C07K 14/00
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11831651

NOVEL SUBSTITUTED QUINOLINE COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS

IPC classification:
A61K 31/47, A61K 31/4709, A61P 11/00, C07D 215/20, C07D 401/04, C07D 401/10, C07D 409/04, C07D 409/14, C07D 413/10, C07D 417/10
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Agent:
Anna-Louise Hally, F. R. Kelly & Co.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11807317

NOVEL DIHYDROPYRIDIN-2(1H)-ONE COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS AND NEUROKININ-3 RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/715, C07D 211/88, C07D 213/22, C07D 401/04, C07D 409/04, C07D 409/14
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11828028

DRILL HEAD LOCKING APPARATUS AND DRILL HEAD

IPC classification:
A61B 17/16
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13167177

Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function

IPC classification:
A61K 31/23, A61K 31/7004, C12Q 1/68
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP13167178

Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function

IPC classification:
A61K 31/12, C12Q 1/68, G01N 33/48
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13167176

Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function

IPC classification:
A61K 31/12, C12Q 1/68, G01N 33/48
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13167174

Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function

IPC classification:
A61K 31/12, C12Q 1/68, G01N 33/48
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13167175

Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function

IPC classification:
A61K 31/12, C12Q 1/68, G01N 33/48
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14864118

CYTIDINE-5-CARBOXAMIDE MODIFIED NUCLEOTIDE COMPOSITIONS AND METHODS RELATED THERETO

IPC classification:
C07H 19/06
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP11769393

APTAMERS TO ss-NGF AND THEIR USE IN TREATING ss-NGF MEDIATED DISEASES AND DISORDERS

IPC classification:
C07H 19/073, C07H 19/10, C07H 21/04, C12N 15/115
Applicant:
Otsuka Pharmaceutical Co., Ltd.
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP14868495

POLYCARBONATES BEARING AROMATIC N-HETEROCYCLES FOR DRUG DELIVERY

IPC classification:
A61K 9/51, A61K 31/704, A61K 31/7088, A61K 38/00, A61K 47/34, C08G 64/16
Applicant:
International Business Machines Corporation (IBM)
Applicant:
Agency for Science, Technology and Research
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP13158346

Detection methods using aptamers

IPC classification:
G01N 33/53
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15701655

MUTAGENESIS METHODS

IPC classification:
C12N 9/22, C12N 15/10, C12N 15/63
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15737714

USE OF PARP INHIBITORS TO TREAT BREAST OR OVARIAN CANCER PATIENTS SHOWING A LOSS OF HETEROZYGOSITY

IPC classification:
C12Q 1/68
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14873831

COGENERATION PLANT

IPC classification:
E04H 5/02, E04H 5/10, E04H 5/12, F01K 23/10, F25B 27/02
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14877091

1-(3-AMINOPROPYL) SUBSTITUTED CYCLIC AMINE COMPOUNDS, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

IPC classification:
A61K 31/454, A61K 31/4545, A61K 31/46, A61P 31/18, C07D 401/14, C07D 409/14, C07D 451/04, C07D 519/00
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15751799

COMPOSITIONS AND METHODS FOR DETECTING MICROORGANISMS

IPC classification:
C12Q 1/68, C40B 30/04, C40B 40/06, G01N 33/00, G01N 33/566
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15721808

ONCOLYTIC VIRUS AND AURORA KINASE INHIBITOR FOR THE TREATMENT OF CANCER

IPC classification:
A61K 31/416, A61K 35/763
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15799703

CRYSTALLINE POWDER OF CYCLIC PEPTIDE COMPOUND, PREPARATION METHOD FOR SAME, AND USES THEREOF

IPC classification:
A61K 38/12, A61P 31/10, C07K 1/02, C07K 7/56
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15729302

NUCLEIC ACID COMPOUNDS FOR BINDING TO COMPLEMENT COMPONENT 3 PROTEIN

IPC classification:
A61K 31/7088, C12N 15/115
Applicant:
Somalogic Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15800606

CRYSTAL OF CYCLIC PEPTIDE COMPOUND, PREPARATION METHOD FOR SAME, AND USES THEREOF

IPC classification:
A61K 38/12, A61P 31/10, C07K 1/02, C07K 7/56
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP16183844

SALTS AND POLYMORPHS OF 8-FLUORO-2-{4-[(METHYLAMINO}METHYL]PHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINO[5,4,3-CD]INDOL-6-ONE

IPC classification:
A61K 31/55, A61K 45/06, A61P 35/00, C07C 57/145, C07C 309/19, C07D 487/06
Applicant:
Pfizer Inc
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
APPLICATION PUBLISHED
EP14894623

RATCHET TOOL

IPC classification:
B25B 15/04, B25B 23/18
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15811279

STEM CELL SUBPOPULATIONS WITH DIFFERENTIAL GSTT1 EXPRESSION OR GENOTYPE

IPC classification:
A61K 35/545, C12N 5/0735, C12N 5/074, C12N 5/0775, C12Q 1/68
Applicant:
Agency for Science, Technology and Research
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15833096

HIGH DOSAGE STRENGTH TABLETS OF RUCAPARIB

IPC classification:
A61K 31/55
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15771320

THERAPEUTIC NANOPARTICLES AND RELATED COMPOSITIONS, METHODS AND SYSTEMS

IPC classification:
A61K 9/107, A61K 9/51, A61K 48/00
Agent:
Richard Ian Clegg, Mewburn Ellis LLP
Status:
Request for examination was made

Please Sign in to use this feature